MUFG Securities EMEA’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$968K Sell
13,822
-390
-3% -$20.2K 0.01% 426
2026
Q1
$722K Hold
14,212
0.01% 450
2025
Q4
$419K Buy
14,212
+7,584
+114% +$206K ﹤0.01% 528
2025
Q3
$171K Buy
6,628
+5,630
+564% +$157K ﹤0.01% 518
2025
Q2
$27.5K Buy
+998
New +$26.3K ﹤0.01% 514

Other funds holding MRNA

MUFG Securities EMEA's MRNA Position: Q2 2026 in Review

MUFG Securities EMEA reduced its Moderna (MRNA) stake by 2.7% in Q2 2026, selling an estimated $20.2K and leaving 13,822 shares worth $968K. The position accounts for 0.01% of the portfolio, ranked #426.

MUFG Securities EMEA first reported a position in MRNA in Q2 2025 and has held it in 5 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • MUFG Securities EMEA held 13,822 shares of Moderna worth $968K as of Q2 2026.
  • MUFG Securities EMEA sold 390 Moderna shares in Q2 2026, an estimated $20.2K.
  • Moderna made up 0.01% of MUFG Securities EMEA's portfolio in Q2 2026, its #426 holding.
  • MUFG Securities EMEA first reported a position in Moderna in Q2 2025 and has held it in 5 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on MUFG Securities EMEA's 13F filing for Q2 2026, filed 12 Aug 2026.